Sabrina Ronen, PhD
|
Title(s) | Professor, Radiology |
---|
School | School of Medicine |
---|
Address | 1700 4th St San Francisco CA 94158
|
---|
Phone | 415-514-4839 |
---|
vCard | Download vCard |
---|
|
|
Biography International Society of Magnetic Resonance in Medicine (ISMRM) | 2016 | | Nominated Senior Fellow | World Molecular Imaging Society | 2015
-
| 2018 | Board of Trustees | Academy of Radiology Research | 2013 | | Distinguished Investigator | International Society of Magnetic Resonance in Medicine (ISMRM) | 2008
-
| 2011 | Annual Meeting Program Committee (AMPC) | CRUK Institute of Cancer Research | 1996 | | ICR Fellowship | Israel Ministry of Science | 1987 | | Eshkol Scholarship |
Overview Sabrina M. Ronen, PhD, is a Professor and Director of the Neuroimaging Research Group in the UCSF Department of Radiology and Biomedical Imaging. Dr. Ronen completed her BS in Chemistry and Biochemistry at the Hebrew University in Jerusalem, Israel, received her MS in Chemistry from San Jose State University, and obtained her PhD in Chemical Physics from The Weizmann Institute of Science in Rehovot, Israel. She then trained as a postdoctoral fellow at the Institut Curie in Paris, France, and started her academic career at the Institute of Cancer Research in London, England.
Dr. Ronen’s Laboratory focuses on developing and mechanistically validating robust non-invasive translatable magnetic resonance (MR)–based biomarkers that can be used to monitor oncogenic transformation and response to therapy. Dr. Ronen has ongoing research projects on monitoring PI3K signaling, detecting the mutational status of isocitrate dehydrogenase, probing the metabolism of brain tumors, and determining the metabolomic profile of pancreatic cancer.
Expertise: Magnetic resonance spectroscopy (MRS), spectroscopic imaging (MRSI), imaging (MRI), metabolism, cancer, bioengineering
Specialty: Preclinical cancer models
Professional Interests: Magnetic resonance, spectroscopy, imaging, cancer, metabolism, cell signaling, biomarkers
Education and Training: • Bachelor of Science: Hebrew University, Jerusalem, Israel - Cum Laude, Chemistry and Biochemistry • Masters of Science: San Jose State University, San Jose - Chemistry • Doctor of Philosophy: Weizmann Institute of Science, Rehovot, Israel - Chemical Physics • Postdoctoral Fellowship: Institut Curie, Paris, France - Imaging • Postdoctoral Fellowship: Harefield Hospital, London, England - Imaging
Research ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Non-invasive assessment of telomere maintenance mechanisms in brain tumors. Nat Commun. 2021 01 04; 12(1):92.
Viswanath P, Batsios G, Mukherjee J, Gillespie AM, Larson PEZ, Luchman HA, Phillips JJ, Costello JF, Pieper RO, Ronen SM. PMID: 33397920.
View in: PubMed Mentions: Fields: Translation: AnimalsCells
-
Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment. Cancer Res. 2020 11 15; 80(22):5098-5108.
Subramani E, Radoul M, Najac C, Batsios G, Molloy AR, Hong D, Gillespie AM, Santos RD, Viswanath P, Costello JF, Pieper RO, Ronen SM. PMID: 32958546.
View in: PubMed Mentions: Fields:
-
Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa088.
Jones LE, Hilz S, Grimmer MR, Mazor T, Najac C, Mukherjee J, McKinney A, Chow T, Pieper RO, Ronen SM, Chang SM, Phillips JJ, Costello JF. PMID: 32904945.
View in: PubMed Mentions:
-
MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma. Theranostics. 2020; 10(19):8757-8770.
PMID: 32754276.
View in: PubMed Mentions: 1 Fields:
-
In vivo detection of ?-glutamyl-transferase up-regulation in glioma using hyperpolarized ?-glutamyl-[1-13C]glycine. Sci Rep. 2020 04 10; 10(1):6244.
Batsios G, Najac C, Cao P, Viswanath P, Subramani E, Saito Y, Gillespie AM, Yoshihara HAI, Larson P, Sando S, Ronen SM. PMID: 32277103.
View in: PubMed Mentions: Fields: Translation: HumansAnimalsCells
-
First hyperpolarized [2-13C]pyruvate MR studies of human brain metabolism. J Magn Reson. 2019 12; 309:106617.
Chung BT, Chen HY, Gordon J, Mammoli D, Sriram R, Autry AW, Le Page LM, Chaumeil MM, Shin P, Slater J, Tan CT, Suszczynski C, Chang S, Li Y, Bok RA, Ronen SM, Larson PEZ, Kurhanewicz J, Vigneron DB. PMID: 31648132.
View in: PubMed Mentions: 5 Fields: Translation: HumansAnimalsPHPublic Health
-
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival. Sci Rep. 2019 07 19; 9(1):10521.
Batsios G, Viswanath P, Subramani E, Najac C, Gillespie AM, Santos RD, Molloy AR, Pieper RO, Ronen SM. PMID: 31324855.
View in: PubMed Mentions: 6 Fields: Translation: HumansAnimalsCells
-
In vivo investigation of hyperpolarized [1,3-13C2]acetoacetate as a metabolic probe in normal brain and in glioma. Sci Rep. 2019 03 04; 9(1):3402.
Najac C, Radoul M, Le Page LM, Batsios G, Subramani E, Viswanath P, Gillespie AM, Ronen SM. PMID: 30833594.
View in: PubMed Mentions: 2 Fields: Translation: AnimalsCells
-
HDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSI. NMR Biomed. 2019 02; 32(2):e4044.
Radoul M, Najac C, Viswanath P, Mukherjee J, Kelly M, Gillespie AM, Chaumeil MM, Eriksson P, Delos Santos R, Pieper RO, Ronen SM. PMID: 30561869.
View in: PubMed Mentions: 4 Fields: Translation: AnimalsCells
-
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology. Neoplasia. 2019 01; 21(1):1-16.
Kurhanewicz J, Vigneron DB, Ardenkjaer-Larsen JH, Bankson JA, Brindle K, Cunningham CH, Gallagher FA, Keshari KR, Kjaer A, Laustsen C, Mankoff DA, Merritt ME, Nelson SJ, Pauly JM, Lee P, Ronen S, Tyler DJ, Rajan SS, Spielman DM, Wald L, Zhang X, Malloy CR, Rizi R. PMID: 30472500.
View in: PubMed Mentions: 37 Fields: Translation: HumansAnimals
-
Late-stage deuteration of 13C-enriched substrates for T1 prolongation in hyperpolarized 13C MRI. Chem Commun (Camb). 2018 May 17; 54(41):5233-5236.
Taglang C, Korenchan DE, von Morze C, Yu J, Najac C, Wang S, Blecha JE, Subramaniam S, Bok R, VanBrocklin HF, Vigneron DB, Ronen SM, Sriram R, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 29726563.
View in: PubMed Mentions: 4 Fields:
-
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner. Cancer Metab. 2018; 6:3.
Viswanath P, Radoul M, Izquierdo-Garcia JL, Luchman HA, Gregory Cairncross J, Pieper RO, Phillips JJ, Ronen SM. PMID: 29619216.
View in: PubMed Mentions:
-
2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas. Cancer Res. 2018 05 01; 78(9):2290-2304.
PMID: 29358170.
View in: PubMed Mentions: 7 Fields: Translation: HumansAnimalsCells
-
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proc Natl Acad Sci U S A. 2017 10 03; 114(40):10743-10748.
Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, Cairncross JG, Perry A, Nelson SJ, Chang SM, Bollen AW, Molinaro AM, Bengtsson H, Olshen AB, Weiss S, Phillips JJ, Luchman HA, Costello JF. PMID: 28916733.
View in: PubMed Mentions: 26 Fields: Translation: HumansCells
-
Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model. Proc Natl Acad Sci U S A. 2017 08 15; 114(33):E6982-E6991.
Guglielmetti C, Najac C, Didonna A, Van der Linden A, Ronen SM, Chaumeil MM. PMID: 28760957.
View in: PubMed Mentions: 17 Fields: Translation: Animals
-
Autophagy-Dependent Shuttling of TBC1D5 Controls Plasma Membrane Translocation of GLUT1 and Glucose Uptake. Mol Cell. 2017 Jul 06; 67(1):84-95.e5.
PMID: 28602638.
View in: PubMed Mentions: 24 Fields: Translation: HumansAnimalsCells
-
Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma. Sci Rep. 2017 03 22; 7:44792.
PMID: 28327577.
View in: PubMed Mentions: 25 Fields: Translation: Humans
-
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. JCI Insight. 2017 01 26; 2(2):e88815.
PMID: 28138554.
View in: PubMed Mentions: 11 Fields: Translation: HumansAnimalsCells
-
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. Cancer Res. 2016 11 15; 76(22):6680-6689.
PMID: 27758882.
View in: PubMed Mentions: 13 Fields: Translation: HumansAnimalsCells
-
MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy. Top Magn Reson Imaging. 2016 Oct; 25(5):187-196.
PMID: 27748711.
View in: PubMed Mentions: 5 Fields: Translation: Humans
-
Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine. Sci Rep. 2016 08 10; 6:31397.
PMID: 27507680.
View in: PubMed Mentions: 7 Fields: Translation: AnimalsCells
-
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. Mol Cancer Res. 2016 10; 14(10):976-983.
PMID: 27430238.
View in: PubMed Mentions: 23 Fields: Translation: HumansCells
-
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring. Neuroimage Clin. 2016; 12:180-9.
PMID: 27437179.
View in: PubMed Mentions: 16 Fields: Translation: HumansCells
-
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters. Oncotarget. 2016 Jun 07; 7(23):34942-55.
PMID: 27144334.
View in: PubMed Mentions: 7 Fields: Translation: HumansCells
-
Imaging Renal Urea Handling in Rats at Millimeter Resolution using Hyperpolarized Magnetic Resonance Relaxometry. Tomography. 2016 Jun; 2(2):125-135.
PMID: 27570835.
View in: PubMed Mentions: 9 Fields:
-
Accelerated high-bandwidth MR spectroscopic imaging using compressed sensing. Magn Reson Med. 2016 08; 76(2):369-79.
PMID: 27228088.
View in: PubMed Mentions: 5 Fields: Translation: Animals
-
Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells. Front Oncol. 2016; 6:60.
PMID: 27014635.
View in: PubMed Mentions:
-
MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival. . 2016 05; 15(5):1113-22.
PMID: 26883274.
View in: PubMed Mentions:
-
1 H-13 C independently tuned radiofrequency surface coil applied for in vivo hyperpolarized MRI. Magn Reson Med. 2016 11; 76(5):1612-1620.
PMID: 26597845.
View in: PubMed Mentions: 1 Fields: Translation: Animals
-
Magnetic Resonance (MR) Metabolic Imaging in Glioma. Brain Pathol. 2015 Nov; 25(6):769-80.
PMID: 26526945.
View in: PubMed Mentions: 11 Fields: Translation: HumansAnimals
-
Metabolic reprogramming of pyruvate dehydrogenase is essential for the proliferation of glioma cells expressing mutant IDH1. Mol Cell Oncol. 2016 Apr 01; 3(2):e1077922.
PMID: 26985452.
View in: PubMed Mentions:
-
Studies of Metabolism Using (13)C MRS of Hyperpolarized Probes. Methods Enzymol. 2015; 561:1-71.
PMID: 26358901.
View in: PubMed Mentions: 20 Fields: Translation: HumansAnimals
-
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. Cancer Res. 2015 Aug 01; 75(15):2999-3009.
PMID: 26045167.
View in: PubMed Mentions: 36 Fields: Translation: HumansCells
-
Metabolic reprogramming in mutant IDH1 glioma cells. PLoS One. 2015; 10(2):e0118781.
PMID: 25706986.
View in: PubMed Mentions: 32 Fields: Translation: Humans
-
Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells. Cancer Res. 2014 Dec 01; 74(23):7115-24.
PMID: 25320009.
View in: PubMed Mentions: 29 Fields: Translation: HumansCells
-
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase. PLoS One. 2014; 9(9):e108289.
PMID: 25243911.
View in: PubMed Mentions: 28 Fields: Translation: HumansCells
-
Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites. Magn Reson Med. 2015 Sep; 74(3):622-633.
PMID: 25213126.
View in: PubMed Mentions: 15 Fields: Translation: HumansAnimalsCells
-
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer. NMR Biomed. 2014 Nov; 27(11):1361-70.
PMID: 25199993.
View in: PubMed Mentions: 7 Fields: Translation: HumansAnimals
-
Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. Cancer Res. 2014 Aug 15; 74(16):4247-57.
PMID: 24876103.
View in: PubMed Mentions: 34 Fields: Translation: HumansAnimalsCells
-
Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell. 2014 May 22; 157(5):1088-103.
PMID: 24855946.
View in: PubMed Mentions: 76 Fields: Translation: HumansAnimalsCells
-
MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition. NMR Biomed. 2014 Jun; 27(6):700-8.
PMID: 24706368.
View in: PubMed Mentions: 6 Fields: Translation: HumansCells
-
Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro Oncol. 2014 May; 16(5):686-95.
PMID: 24366912.
View in: PubMed Mentions: 58 Fields: Translation: HumansAnimalsCells
-
Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage. PLoS One. 2013; 8(5):e62351.
PMID: 23667469.
View in: PubMed Mentions: 7 Fields: Translation: HumansCells
-
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells. PLoS One. 2013; 8(4):e62610.
PMID: 23626839.
View in: PubMed Mentions: 17 Fields: Translation: HumansCells
-
Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma. PLoS One. 2013; 8(2):e57610.
PMID: 23451252.
View in: PubMed Mentions: 27 Fields: Translation: HumansCells
-
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance. Clin Cancer Res. 2013 Apr 01; 19(7):1773-83.
PMID: 23307858.
View in: PubMed Mentions: 80 Fields: Translation: HumansAnimalsCells
-
Non-invasive in vivo assessment of IDH1 mutational status in glioma. Nat Commun. 2013; 4:2429.
PMID: 24019001.
View in: PubMed Mentions: 48 Fields: Translation: HumansAnimalsCells
-
Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells. NMR Biomed. 2013 Mar; 26(3):299-306.
PMID: 22945392.
View in: PubMed Mentions: 28 Fields: Translation: HumansCells
-
Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med. 2013 Jul; 70(1):33-9.
PMID: 22851374.
View in: PubMed Mentions: 15 Fields: Translation: HumansAnimalsCells
-
Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla. Neuro Oncol. 2012 Aug; 14(8):1050-61.
PMID: 22670012.
View in: PubMed Mentions: 7 Fields: Translation: HumansAnimalsCells
-
Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma. Neuro Oncol. 2012 Mar; 14(3):315-25.
PMID: 22156546.
View in: PubMed Mentions: 43 Fields: Translation: HumansCells
-
Vascular patterning and permeability in prostate cancer models with differing osteogenic properties. NMR Biomed. 2012 Jun; 25(6):843-51.
PMID: 22134886.
View in: PubMed Mentions: 1 Fields: Translation: HumansAnimalsCells
-
Choline metabolism in malignant transformation. Nat Rev Cancer. 2011 Nov 17; 11(12):835-48.
PMID: 22089420.
View in: PubMed Mentions: 228 Fields: Translation: HumansAnimalsCells
-
Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment. PLoS One. 2011; 6(10):e26155.
PMID: 22022547.
View in: PubMed Mentions: 19 Fields: Translation: HumansCells
-
Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells. NMR Biomed. 2012 Feb; 25(2):379-88.
PMID: 22253088.
View in: PubMed Mentions: 13 Fields: Translation: HumansCells
-
Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage. 2012 Jan 02; 59(1):193-201.
Chaumeil MM, Ozawa T, Park I, Scott K, James CD, Nelson SJ, Ronen SM. PMID: 21807103.
View in: PubMed Mentions: 48 Fields: Translation: HumansAnimals
-
Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. J Magn Reson Imaging. 2011 Jun; 33(6):1284-90.
Park I, Bok R, Ozawa T, Phillips JJ, James CD, Vigneron DB, Ronen SM, Nelson SJ. PMID: 21590996.
View in: PubMed Mentions: 61 Fields: Translation: HumansAnimalsCells
-
Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell. 2011 Jan 15; 22(2):165-78.
Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM, Debnath J. PMID: 21119005.
View in: PubMed Mentions: 190 Fields: Translation: HumansAnimalsCells
-
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2. Breast Cancer Res. 2010; 12(5):R84.
Brandes AH, Ward CS, Ronen SM. PMID: 20946630.
View in: PubMed Mentions: 18 Fields: Translation: HumansCells
-
Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and myc activity downstream of platelet-derived growth factor receptor. Cancer Res. 2010 Oct 01; 70(19):7400-10.
Dafni H, Larson PE, Hu S, Yoshihara HA, Ward CS, Venkatesh HS, Wang C, Zhang X, Vigneron DB, Ronen SM. PMID: 20858719.
View in: PubMed Mentions: 29 Fields: Translation: HumansAnimalsCells
-
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. Neuro Oncol. 2010 Jun; 12(6):559-69.
Koul D, Shen R, Kim YW, Kondo Y, Lu Y, Bankson J, Ronen SM, Kirkpatrick DL, Powis G, Yung WK. PMID: 20156803.
View in: PubMed Mentions: 52 Fields: Translation: HumansAnimalsCells
-
Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res. 2010 Feb 15; 70(4):1296-305.
Ward CS, Venkatesh HS, Chaumeil MM, Brandes AH, Vancriekinge M, Dafni H, Sukumar S, Nelson SJ, Vigneron DB, Kurhanewicz J, James CD, Haas-Kogan DA, Ronen SM. PMID: 20145128.
View in: PubMed Mentions: 71 Fields: Translation: HumansAnimalsCells
-
Dynamic nuclear polarization in metabolic imaging of metastasis: common sense, hypersense and compressed sensing. Cancer Biomark. 2010; 7(4):189-99.
PMID: 21576812.
View in: PubMed Mentions: 1 Fields: Translation: Humans
-
Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation. Magn Reson Med. 2008 Oct; 60(4):822-33.
Dafni H, Kim SJ, Bankson JA, Sankaranarayanapillai M, Ronen SM. PMID: 18816866.
View in: PubMed Mentions: 12 Fields: Translation: AnimalsCells
-
Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine. . 2008 Aug; 7(8):2556-65.
Ross J, Najjar AM, Sankaranarayanapillai M, Tong WP, Kaluarachchi K, Ronen SM. PMID: 18723500.
View in: PubMed Mentions:
-
Monitoring histone deacetylase inhibition in vivo: noninvasive magnetic resonance spectroscopy method. Mol Imaging. 2008 Mar-Apr; 7(2):92-100.
Sankaranarayanapillai M, Tong WP, Yuan Q, Bankson JA, Dafni H, Bornmann WG, Soghomonyan S, Pal A, Ramirez MS, Webb D, Kaluarachchi K, Gelovani JG, Ronen SM. PMID: 18706291.
View in: PubMed Mentions: 14 Fields: Translation: HumansAnimalsCells
-
Detection of histone deacetylase inhibition by noninvasive magnetic resonance spectroscopy. . 2006 May; 5(5):1325-34.
Sankaranarayanapillai M, Tong WP, Maxwell DS, Pal A, Pang J, Bornmann WG, Gelovani JG, Ronen SM. PMID: 16731766.
View in: PubMed Mentions:
-
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells. . 2006 Jan; 5(1):187-96.
Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM. PMID: 16432178.
View in: PubMed Mentions:
-
Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition. Cancer Res. 2005 Apr 15; 65(8):3356-63.
Beloueche-Babari M, Jackson LE, Al-Saffar NM, Workman P, Leach MO, Ronen SM. PMID: 15833869.
View in: PubMed Mentions: 29 Fields: Translation: HumansCells
-
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models. J Natl Cancer Inst. 2003 Nov 05; 95(21):1624-33.
Chung YL, Troy H, Banerji U, Jackson LE, Walton MI, Stubbs M, Griffiths JR, Judson IR, Leach MO, Workman P, Ronen SM. PMID: 14600095.
View in: PubMed Mentions: 39 Fields: Translation: HumansAnimals
-
Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells. Br J Cancer. 2002 Mar 18; 86(6):963-70.
Al-Saffar NM, Titley JC, Robertson D, Clarke PA, Jackson LE, Leach MO, Ronen SM. PMID: 11953830.
View in: PubMed Mentions: 25 Fields: Translation: HumansCells
-
Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells. Br J Cancer. 2001 Mar 02; 84(5):691-6.
Ronen SM, Jackson LE, Beloueche M, Leach MO. PMID: 11237392.
View in: PubMed Mentions: 27 Fields: Translation: AnimalsCells
-
Imaging biochemistry: applications to breast cancer. Breast Cancer Res. 2001; 3(1):36-40.
Ronen SM, Leach MO. PMID: 11250743.
View in: PubMed Mentions: 14 Fields: Translation: HumansAnimalsCells
-
Treatment of SW620 cells with Tomudex and oxaliplatin induces changes in 2-deoxy-D-glucose incorporation associated with modifications in glucose transport. J Nucl Med. 2000 Oct; 41(10):1753-9.
Smith TA, Maisey NR, Titley JC, Jackson LE, Leach MO, Ronen SM. PMID: 11038008.
View in: PubMed Mentions: 2 Fields: Translation: HumansCells
-
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia. 2000 Jan-Apr; 2(1-2):152-65.
Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. PMID: 10933074.
View in: PubMed Mentions: 42 Fields: Translation: HumansAnimals
-
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Br J Cancer. 1999 Jun; 80(7):1035-41.
Ronen SM, DiStefano F, McCoy CL, Robertson D, Smith TA, Al-Saffar NM, Titley J, Cunningham DC, Griffiths JR, Leach MO, Clarke PA. PMID: 10362112.
View in: PubMed Mentions: 12 Fields: Translation: HumansAnimalsCells
-
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed. 1998 Nov; 11(7):314-40.
Leach MO, Verrill M, Glaholm J, Smith TA, Collins DJ, Payne GS, Sharp JC, Ronen SM, McCready VR, Powles TJ, Smith IE. PMID: 9859939.
View in: PubMed Mentions: 33 Fields: Translation: Humans
-
Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors. NMR Biomed. 1994 Sep; 7(6):278-86.
Ronen SM, Volk A, Mispelter J. PMID: 7841024.
View in: PubMed Mentions: 7 Fields: Translation: AnimalsCells
-
The application of 13C NMR to the characterization of phospholipid metabolism in cells. Magn Reson Med. 1992 Jun; 25(2):384-9.
Ronen SM, Degani H. PMID: 1319537.
View in: PubMed Mentions: 7 Fields: Translation: Humans
-
Lipid metabolism in large T47D human breast cancer spheroids: 31P- and 13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta. 1992 Mar 20; 1138(3):203-12.
Ronen SM, Rushkin E, Degani H. PMID: 1547282.
View in: PubMed Mentions: 5 Fields: Translation: HumansCells
-
Lipid metabolism in T47D human breast cancer cells: 31P and 13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta. 1991 Oct 16; 1095(1):5-16.
Ronen SM, Rushkin E, Degani H. PMID: 1657190.
View in: PubMed Mentions: 12 Fields: Translation: HumansCells
-
NMR studies of the lipid metabolism of T47D human breast cancer spheroids. FEBS Lett. 1990 Jun 18; 266(1-2):147-9.
Ronen SM, Stier A, Degani H. PMID: 2365062.
View in: PubMed Mentions: 3 Fields: Translation: HumansCells
-
Studies of the metabolism of human breast cancer spheroids by NMR. Magn Reson Med. 1989 Nov; 12(2):274-81.
Ronen S, Degani H. PMID: 2559291.
View in: PubMed Mentions: 4 Fields: Translation: HumansCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
Year | Publications |
---|
1991 | 1 | 1992 | 2 | 1994 | 1 | 1998 | 1 | 1999 | 1 | 2000 | 3 | 2001 | 1 | 2002 | 1 | 2003 | 1 | 2005 | 1 | 2006 | 2 | 2008 | 3 | 2010 | 6 | 2011 | 7 | 2012 | 3 | 2013 | 6 | 2014 | 7 | 2015 | 6 | 2016 | 10 | 2017 | 5 | 2018 | 5 | 2019 | 3 | 2020 | 4 | 2021 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|